Target intelligence / Profile preview

RNA, U6 small nuclear 534, pseudogene (RNU6-534P)

Target
RNU6-534P
Molecular classification
Other (Pseudogene, noncoding RNA)
01

Overview

RNA, U6 small nuclear 534, pseudogene (RNU6-534P) is a processed pseudogene copy of the U6 small nuclear RNA gene family. U6 snRNA is normally an essential non-coding RNA component of the spliceosome, which catalyzes pre-mRNA splicing in eukaryotes[3][1]. Pseudogenes such as RNU6-534P do not encode functional RNA or protein and are typically regarded as nonfunctional genomic remnants generated by retrotransposition events[5]. U6 snRNA pseudogenes are frequent in the human genome, resulting from L1-mediated reverse transcription and integration[5]. There is no evidence that RNU6-534P has a functional role, disease association, or is a direct target for drugs or therapeutic intervention[2][5]. Accordingly, RNU6-534P is not considered a therapeutic target, receptor, or actionable biomolecule. **Key context:** - The canonical gene for functional activity is *U6 small nuclear RNA* (U6 snRNA), a critical spliceosomal component[3][1]. - Pseudogenes like RNU6-534P are structurally similar to their parent gene but are nonfunctional due to lack of expression or sequence integrity[5]. - RNU6-534P cannot serve as a drug target, biomarker, or have disease relevance unless otherwise experimentally shown, which current references do not indicate[2][5].

Other names
RNU6-534PRNA, U6 small nuclear 534 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 534, pseudogene (RNU6-534P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 534, pseudogene (RNU6-534P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call